This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Greenberg: Post-Earnings Wrap - Boulder Brands, MercadoLibre

By: Herb Greenberg | 03/03/14 - 12:41 PM EST

(A broader version of this previously ran Friday morning on Herb Greenberg's Reality Check)

SAN DIEGO (TheStreet) -- Some quick takes, post-earnings, on Reality Check Watch List companies:

Boulder Brands

It's still unclear why Boulder (BDBD), the gluten-free play, rose after reporting earnings last week. The company missed on GAAP numbers (not that GAAP matters to BDBD investors, who have been encouraged to look at "adjusted" non-GAAP results) and guided down for 2014 for the third time since November. Even adjusted results aren't what they're cracked up to be. Adjusted EPS would have missed, but instead beat after adding back restructuring and relocation-related charges, which added 2.5 cents to earnings per share. Without it the company would have missed by $0.01.

As I wrote in a broader piece on Reality Check, the company reiterated on its call that it believes gluten-free is a trend. I say it's a fad.

Anybody with a serious interest should check out Dr. Peter Green's comments on this NPR roundtable.

He heads Columbia University's Celiac Center. He is widely considered the expert on celiac and gluten-related issues and he says there is "no evidence at all" for all of the gluten-related claims.

MercadoLibre


Shares of MercadoLibre (MELI), the Amazon (AMZN)/eBay (EBAY) of Latin America zoomed after the company reported better-than-expected results.

However, the company steers investors to look at "units sold" rather than actual numbers because it strips out currency issues. Well, units sold rose by 20%, which is less than analysts had expected.

Asked for several quarters worth of unit growth ex-Venezuela, CFO Pedro Arnt said, "I don't have that off the top of my head right now."

-- Written by Herb Greenberg in San Diego

Herb Greenberg, editor of Herb Greenberg's Reality Check, is a contributor to CNBC. He does not own shares, short or trade shares in an individual corporate security. He can be reached at herbonthestreet@thestreet.com.

Other Posts In Herb's A Dose of Reality:

Get More Investment Ideas:

Cramer: Russia's Impact Finally Being Felt

07/31/14 - 11:25 AM EDT

Sozzi: Mixed Signals From the Execs

07/31/14 - 10:11 AM EDT

Kass: Has the Auto Industry Peaked?

07/31/14 - 06:00 AM EDT

Cramer: A Turn Could Be Around the Corner

07/30/14 - 10:36 AM EDT

Melvin: Buying Brazilian Bargains

07/30/14 - 08:41 AM EDT

To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.

Markets

DOW 16,563.30 -317.06 -1.88%
S&P 500 1,930.67 -39.40 -2.00%
NASDAQ 4,369.7730 -93.1290 -2.09%

Herb's Tweets

Brokerage Partners

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs